JAMA internal medicine
-
JAMA internal medicine · Jun 2016
Comparative StudyAssociation of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Pharmaceutical industry payments to physicians may affect prescribing practices and increase costs if more expensive medications are prescribed. ⋯ Industry payments to physicians are associated with higher rates of prescribing brand-name statins. As the United States seeks to rein in the costs of prescription drugs and make them less expensive for patients, our findings are concerning.
-
JAMA internal medicine · May 2016
Quasi-Experimental Evaluation of the Effectiveness of a Large-Scale Readmission Reduction Program.
Feasibility, effectiveness, and sustainability of large-scale readmission reduction efforts are uncertain. The Greater New Haven Coalition for Safe Transitions and Readmission Reductions was funded by the Center for Medicare & Medicaid Services (CMS) to reduce readmissions among all discharged Medicare fee-for-service (FFS) patients. ⋯ This large-scale readmission reduction program reduced readmissions by 9.3% among the full population targeted by the CMS despite being delivered only to high-risk patients. However, it did not achieve the goal reduction set by the CMS.